Literature DB >> 26824997

Invariant Standardized Estimated Parameter Change for Model Modification in Covariance Structure Analysis.

C P Chou, P M Bentler.   

Abstract

An estimated parameter change (EPC) has recently been introduced as another criterion to be considered in the process of model modification in covariance structure analysis. Kaplan (1989) provided a standardized version of this statistic (SEPC-K). It has been found that SEPC-K is only partially standardized; specifically, it is not invariant under different scalings of latent and measured variables. In this article, a new SEPC that is invariant to the original metrics of the measured and latent variables is suggested for use in model modification. A multivariate estimated parameter change (MEPC) which estimates changes for a set of fixed parameters to be freed simultaneously is also introduced. A standardized MEPC (SMEPC) is, furthermore, provided. Because there are now three different types of standardized solutions in structural modeling programs, general discussion of standardized solution in covariance structure analysis is provided. The inappropriate use of standardization for scale-specific models is noted.

Year:  1993        PMID: 26824997     DOI: 10.1207/s15327906mbr2801_6

Source DB:  PubMed          Journal:  Multivariate Behav Res        ISSN: 0027-3171            Impact factor:   5.923


  1 in total

1.  Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic.

Authors:  Mark Shevlin; Sarah Butter; Orla McBride; Jamie Murphy; Jilly Gibson-Miller; Todd K Hartman; Liat Levita; Liam Mason; Anton P Martinez; Ryan McKay; Thomas Va Stocks; Kate M Bennett; Philip Hyland; Frédérique Vallieres; Carmen Valiente; Carmelo Vazquez; Alba Contreras; Vanesa Peinado; Almudena Trucharte; Marco Bertamini; Anna Panzeri; Giovanni Bruno; Umberto Granziol; Giuseppe Mignemi; Andrea Spoto; Giulio Vidotto; Richard P Bentall
Journal:  BMC Psychiatry       Date:  2022-03-01       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.